SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Medical Industries Of America, MIOA

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mr. ed who wrote (515)4/12/1999 10:29:00 AM
From: William Nehls  Read Replies (1) of 570
 
When we look at the combined companies of MIOA,AESI and NAtional Diagnostics(NATD), the total number of shares is quite large. The merger places MIOA at a 1 for 1 with AESI. If AESI does an IPO the value of its stock is unknown but would have to be north of $5.00. AESI is also buying NATD at a buy out value of $3.50sh (currently trading at $.75. There is also a Canadian company involved called Optimark which AESI is buying. When I EMailed Broes last month he indicated that the NATD deal was to happen soon probably when the IPO is completed. If this is the case then both MIOA and NATD appear very undervalued. Does anyone have any thoughts here? Mioa is starting to move up while NATD has not. I don't know much about Optimark.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext